Health Condition 1: K21- Gastro-esophageal reflux disease
Conditions
Interventions
Intervention1: STOMAFIT ORAL LIQUID: Treatment of Gastritis
DOSE: 5 to 10mL diluted in 30 mL water
Frequency 3 to 4 times daily
Route of administration: Oral
Control Intervention1: NOT APPLICABLE:
Sponsors
SUNCARE FORMULATIONS PVT LTD
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male and female subjects 18-60 years of age 2. Patients having gastrointestinal illness; signs and symptoms confirmed from clinical judgement 3. Patients willing to give informed consent for the Active PMS and willing to comply with all the study procedure and requiremnets
Exclusion criteria
Exclusion criteria: 1. History of HIV positive patients 2. Chronic heart failure, respiratory failure or chronic liver and renal failure. 3. Patient with active cancer. 4. Female who is pregnant, planning a pregnancy (during the course of the study) or nursing a child 5. Certain medications that may interfere with the study medication (these will be identified by the study Investigator).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Relief in signs and / or symptoms of patientsâ?? disease. Each symptom or patient complaint will be given intensity score, to describe its intensity from mild to severe, on the Numeric Rating Scale of 01 to 10 starting mildest intensity from 01. Following is an indicative Numerical Rating Scale for measurement of pain intensityTimepoint: 1-3 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluate Efficacy of STOMAFITTimepoint: 1-3 weeks | — |
Countries
India
Contacts
Public ContactDr Nimesh Patel
Sanjeevani Heart & Medical Hosptial
Outcome results
None listed